Literature DB >> 3778447

31P-NMR spectroscopy demonstrates decreased ATP levels in vivo as an early response to photodynamic therapy.

T L Ceckler, R G Bryant, D P Penney, S L Gibson, R Hilf.   

Abstract

31P-Nuclear magnetic resonance was used to monitor in situ phosphorus containing compounds in mammary tumors after photodynamic therapy, consisting of administration of hematoporphyrin derivative followed by photoradiation of the lesion. A rapid decrease in ATP along with an increase in Pi resonance intensities was observed. The beta-ATP/Pi ratio decreased by 1 hour, dropping in 2 to 8 hours to 0 to 20 percent of that found prior to photoradiation. Disrupted cells and pycnotic nuclei were observed 48 to 72 hours after photoradiation to a depth of approximately 5 mm. Together with previous studies in vitro, reduction in tumor ATP levels appears to be an early biochemical response to photodynamic therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3778447     DOI: 10.1016/0006-291x(86)91086-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Mitochondria are targets of photodynamic therapy.

Authors:  Russell Hilf
Journal:  J Bioenerg Biomembr       Date:  2007-02       Impact factor: 2.945

2.  Increased efficacy of photodynamic therapy of R3230AC mammary adenocarcinoma by intratumoral injection of Photofrin II.

Authors:  S L Gibson; K R van der Meid; R S Murant; R Hilf
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

3.  High-field magnetic resonance imaging of the response of human prostate cancer to Pc 4-based photodynamic therapy in an animal model.

Authors:  Baowei Fei; Hesheng Wang; Joseph D Meyers; Denise K Feyes; Nancy L Oleinick; Jeffrey L Duerk
Journal:  Lasers Surg Med       Date:  2007-10       Impact factor: 4.025

4.  Ca(2+)-mediated prostaglandin E2 induction reduces haematoporphyrin-derivative-induced cytotoxicity of T24 human bladder transitional carcinoma cells in vitro.

Authors:  L C Penning; M J Keirse; J VanSteveninck; T M Dubbelman
Journal:  Biochem J       Date:  1993-05-15       Impact factor: 3.857

5.  In vivo magnetic resonance imaging of the effects of photodynamic therapy.

Authors:  N J Dodd; J V Moore; D G Poppitt; B Wood
Journal:  Br J Cancer       Date:  1989-08       Impact factor: 7.640

6.  31P magnetic resonance spectroscopy as a predictor of efficacy in photodynamic therapy using differently charged zinc phthalocyanines.

Authors:  J C Bremner; S R Wood; J K Bradley; J Griffiths; G E Adams; S B Brown
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

7.  Evaluation of the effects of photodynamic therapy with phosphorus 31 magnetic resonance spectroscopy.

Authors:  M Nishiwaki; Y Fujise; T O Yoshida; E Matsuzawa; Y Nishiwaki
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

8.  Hetergeneous tumour response to photodynamic therapy assessed by in vivo localised 31P NMR spectroscopy.

Authors:  T L Ceckler; S L Gibson; S D Kennedy; R Hill; R G Bryant
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

9.  31P-nuclear magnetic resonance spectroscopy in vivo of six human melanoma xenograft lines: tumour bioenergetic status and blood supply.

Authors:  H Lyng; D R Olsen; T E Southon; E K Rofstad
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

10.  Magnetic resonance spectroscopic studies on 'real-time' changes in RIF-1 tumour metabolism and blood flow during and after photodynamic therapy.

Authors:  J C Bremner; J K Bradley; I J Stratford; G E Adams
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.